Pfizer (PFE)

Add to Watchlists Create an Alert
29.12 -0.18  -0.61%   NYSE May 23, 4:58PM BATS Real time Currency in USD

Pfizer Free Cash Flow:

4.762B for Dec. 31, 2012
View Full Chart

Pfizer Free Cash Flow Chart

    Pfizer Historical Free Cash Flow Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 4.762B
    Sept. 30, 2012 4.718B
    June 30, 2012 3.727B
    March 31, 2012 2.52B
    Dec. 31, 2011 4.663B
    Sept. 30, 2011 3.985B
    June 30, 2011 5.54B
    March 31, 2011 4.392B
    Dec. 31, 2010 5.711B
    Sept. 30, 2010 6.395B
    June 30, 2010 4.50B
    March 31, 2010 -6.665B
    Dec. 31, 2009 4.403B
    Sept. 30, 2009 3.84B
    June 30, 2009 4.245B
    March 31, 2009 2.894B
    Dec. 31, 2008 5.584B
    Sept. 30, 2008 3.508B
    June 30, 2008 4.657B
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro

    About Free Cash Flow

    Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.

    According to many investors, free cash flow is the best indication of a company's ability to generate cash.
    Learn More

    Get data for

    PFE Free Cash Flow Benchmarks

    Companies
    Sanofi
    Novartis 1.178B
    Merck 1.031B

    PFE Free Cash Flow Rankings

    Overall 99th percentile
    10 of 8006
    Sector 99th percentile
    1 of 686 in Healthcare
    Industry 98th percentile
    1 of 55 in Drug Manufacturers - Major

    PFE Free Cash Flow Range, Past 5 Years

    Minimum -6.665B Mar 2010
    Maximum 6.395B Sep 2010
    Average 3.862B